Open AccessSerum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
Author(s) -
Ming Zhang,
Wei Han,
Yijuan Xu,
Dapeng Li,
Qun Xue
Publication year - 2021
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s290925
Subject(s) - medicine , receiver operating characteristic , logistic regression , biomarker , area under the curve , disease , gastroenterology , area under curve , oncology , biochemistry , chemistry , pharmacokinetics
Although numerous microRNAs (miRNAs) have been discovered to participate in the progression of Alzheimer's disease (AD), they are still difficult to apply in clinical work. Thus, the identification of novel miRNAs and clarification of their clinical significance are importing for improving the diagnosis and treatment of AD. The purpose of this study was to analyze the expression of miR-128 and its diagnostic value in patients with AD.